查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405788

中心實驗室市場規模、佔有率、趨勢分析報告：按服務、按最終用途、按地區、細分市場預測，2024-2030 年

Central Lab Market Size, Share & Trends Analysis Report By Service (Genetic Services, Biomarker Services), By End-use (Pharmaceutical Companies, Biotechnology Companies), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

中心實驗室市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球中心實驗室市場規模將達到50.5億美元，2024年至2030年複合年成長率為6.44%。

由於研發投資增加以及申辦者和臨床實驗更加重視降低研究成本，預計預測期內複合年成長率為 6.50%。中心業務營運外包是推動市場成長的關鍵因素。

中心實驗室業務外包是臨床試驗產業的成長趨勢，預計將為中心實驗室創造利潤豐厚的商機。臨床實驗和申辦者外包了大約 80% 的中心實驗室業務，更喜歡提供端到端整合服務的實驗室。

近年來，由於大流行期間對製藥業的關注日益增加，研發投資激增。隨著我們進入大流行的第三年，對科學的投資加強了研發管線，多項臨床試驗已經開始。疫情期間，介入研究活動穩定擴大。製藥業開發了新的試驗實施方法來管理大流行期間正在進行的臨床試驗。

這場大流行也創造了新的成長機會，包括人們更加關注開發 mRNA 疫苗和探索幾種 COVID-19治療方法。然而，樣本處理、供應鏈和物流對於送到臨床實驗室的樣本起著至關重要的作用。這些樣品高度敏感，需要快速物流和溫度控制，從而保持樣品穩定性以獲得最準確的結果。

中小型中央偵測機構的崛起正在加劇全球競爭。中小型中心實驗室的存在在亞太等發展中地區非常突出。此外，在新興經濟體進行臨床試驗的成本較低，有利於選擇位於這些地區的中心實驗室。這是由於較低的物流成本和靠近臨床試驗施行地點。

中央實驗室市場報告亮點

  • 由於基因分析在臨床研究中的重要性日益增加，預計基因服務產業將以最快的速度成長。
  • 策略性收購是影響市場動態變化的因素之一。例如，大中型企業為了加強全球擴張或進入新業務領域而進行收購。
  • 由於干預研究和研究投資的增加，製藥公司在最終用途方面佔據了最大的市場佔有率。
  • 由於糖尿病和癌症等疾病領域的個體化醫療保健相關臨床試驗中基因檢測的需求不斷增加，2023年的全球市場將由北美主導。
  • 該市場的主要企業包括 ACM Global Laboratories、Labconnect、Cerba Research、Eurofins Scientific、Medicover Integrated Clinical Services 和 Versiti。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素
    • 加大臨床試驗研發投入
    • 新藥需求不斷成長
    • 中央檢驗業務外包
    • 降低藥物研究成本
  • 市場抑制因素分析
    • 物流和樣品處理
  • 營商環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
    • COVID-19感染疾病的影響分析

第4章服務業務分析

  • 中心實驗室市場：服務波動分析
  • 遺傳服務
  • 生物標誌服務
  • 微生物學服務
  • 解剖病理學/組織學
  • 檢體管理及儲存
  • 特種化學品服務
  • 其他

第5章 最終用途業務分析

  • 中心實驗室市場：最終用途變化分析
  • 製藥公司
  • 生技公司
  • 學術研究所

第6章 區域業務分析

  • 2023年及2030年按地區市場佔有率
  • 北美洲
    • 北美中心實驗室市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲中心實驗室市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太中心實驗室市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲中心實驗室市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA 中心實驗室市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭形勢

  • 參與企業概況
  • 財務績效
  • 參與企業
    • 市場領導者
    • 2023 年中心實驗室市場佔有率分析
    • 公司簡介
    • 策略規劃
Product Code: GVR-4-68039-962-2

Central Lab Market Growth & Trends:

The global central lab market size is expected to reach USD 5.05 billion by 2030, expanding at a CAGR of 6.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 6.50% during the forecast period, driven by the increasing investment in R&D and increased focus of sponsors & investigators on reducing research costs. The outsourcing of central lab work is a significant factor driving the market growth.

Outsourcing central lab work is a rising trend in the clinical trial industry, which is expected to create lucrative business opportunities for central labs. The investigators and sponsors outsource ~80% of the central lab work and prefer the labs that provide end-to-end integrated services.

Investment in R&D has witnessed a surge in past years, which can be attributed to the enhanced focus on the pharmaceutical industry during the pandemic. As we enter the third year of the pandemic, investment in science has enhanced the pipeline and several clinical trials have been initiated. Over the pandemic, activity in interventional studies grew steadily. The pharmaceutical industry developed a new way of conducting trials for the management of ongoing clinical trials during the pandemic.

The pandemic has also created new growth opportunities, with an increasing focus on mRNA vaccine development and investigations for several COVID-19 treatment options. However, sample handling, supply chain, and logistics play a significant role in the sample sent to clinical labs. These samples are highly sensitive and require fast logistics with temperature control, thereby maintaining sample stability to get the most accurate results.

The rise of small- and medium-scale central laboratories is intensifying the competition globally. The presence of small- and medium-scale central labs is highly prominent in developing regions such as the Asia Pacific. These laboratories are becoming critical in the management of clinical trials globally owing to the availability of central laboratory services at 20%-35% lower prices, when compared to Europe and the U.S. Furthermore, the lower cost of conducting clinical trials in the developing economies facilitates the selection of central laboratories present in these regions, which can be attributed to lower logistic costs and presence near the trial location.

Central Lab Market Report Highlights:

  • The genetic services segment is anticipated to grow at the fastest growth rate, owing to the increasing significance of genetic analysis in clinical studies
  • Strategic acquisitions are one of the factors influencing the changing dynamics of the market. For instance, players are acquired by medium and large-scale enterprises for enhancing their global reach and entering new business segments
  • Pharmaceutical companies held the largest market share by end-use, attributable to an increasing number of interventional studies and investment into research
  • North America dominated the global market in 2023, the increasing need for genetic testing in clinical trials related to personalized healthcare in disease areas, such as diabetes & cancers
  • Key players in the market include ACM Global Laboratories, Labconnect, Cerba Research, Eurofins Scientific, Medicover Integrated Clinical Services, and Versiti

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Rising R&D investment in clinical trial
    • 3.4.2. Escalating demand for novel drugs
    • 3.4.3. Outsourcing of central lab work
    • 3.4.4. Reducing the cost of drug research
  • 3.5. Market Restraint Analysis
    • 3.5.1. Logistics and sample handling
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Service Business Analysis

  • 4.1. Central Lab Market: Service Movement Analysis
  • 4.2. Genetic Services
    • 4.2.1. Genetic Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.3. Biomarker Services
    • 4.3.1. Biomarker Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.4. Microbiology Services
    • 4.4.1. Microbiology Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.5. Anatomic Pathology/Histology
    • 4.5.1. Anatomic Pathology/Histology Central Lab Market, 2018 - 2030 (USD Million)
  • 4.6. Specimen Management and Storage
    • 4.6.1. Specimen Management and Storage Central Lab Market, 2018 - 2030 (USD Million)
  • 4.7. Special Chemistry Services
    • 4.7.1. Special Chemistry Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Central Lab Market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. Central Lab Market: End-Use Movement Analysis
  • 5.2. Pharmaceutical Companies
    • 5.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 5.3. Biotechnology Companies
    • 5.3.1. Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.4. Academic and Research Institutes
    • 5.4.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Central Lab Market Share By Region, 2023 & 2030
  • 6.2. North America
    • 6.2.1. North America Central lab market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Target Disease Prevalence
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. Regulatory Framework
      • 6.2.2.5. Reimbursement Scenario
      • 6.2.2.6. U.S. Central lab market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Regulatory Framework
      • 6.2.3.5. Reimbursement Scenario
      • 6.2.3.6. Canada Central lab market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Central lab market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Target Disease Prevalence
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Regulatory Framework
      • 6.3.2.5. Reimbursement Scenario
      • 6.3.2.6. Germany Central lab market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Regulatory Framework
      • 6.3.3.5. Reimbursement Scenario
      • 6.3.3.6. UK Central lab market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Regulatory Framework
      • 6.3.4.5. Reimbursement Scenario
      • 6.3.4.6. France Central lab market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Regulatory Framework
      • 6.3.5.5. Reimbursement Scenario
      • 6.3.5.6. Italy Central lab market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Regulatory Framework
      • 6.3.6.5. Reimbursement Scenario
      • 6.3.6.6. Spain Central lab market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Regulatory Framework
      • 6.3.7.5. Reimbursement Scenario
      • 6.3.7.6. Denmark Central lab market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Regulatory Framework
      • 6.3.8.5. Reimbursement Scenario
      • 6.3.8.6. Sweden Central lab market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Regulatory Framework
      • 6.3.9.5. Reimbursement Scenario
      • 6.3.9.6. Norway Central lab market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Central lab market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Regulatory Framework
      • 6.4.2.5. Reimbursement Scenario
      • 6.4.2.6. Japan Central lab market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Regulatory Framework
      • 6.4.3.5. Reimbursement Scenario
      • 6.4.3.6. China Central lab market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Regulatory Framework
      • 6.4.4.5. Reimbursement Scenario
      • 6.4.4.6. India Central lab market, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Regulatory Framework
      • 6.4.5.5. Reimbursement Scenario
      • 6.4.5.6. South Korea Central lab market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Regulatory Framework
      • 6.4.6.5. Reimbursement Scenario
      • 6.4.6.6. Australia Central lab market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Regulatory Framework
      • 6.4.7.5. Reimbursement Scenario
      • 6.4.7.6. Thailand Central lab market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Central lab market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Regulatory Framework
      • 6.5.2.5. Reimbursement Scenario
      • 6.5.2.6. Brazil Central lab market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Regulatory Framework
      • 6.5.3.5. Reimbursement Scenario
      • 6.5.3.6. Mexico Central lab market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Regulatory Framework
      • 6.5.4.5. Reimbursement Scenario
      • 6.5.4.6. Argentina Central lab market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Central lab market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Regulatory Framework
      • 6.6.2.5. Reimbursement Scenario
      • 6.6.2.6. South Africa Central lab market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Regulatory Framework
      • 6.6.3.5. Reimbursement Scenario
      • 6.6.3.6. Saudi Arabia Central lab market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Regulatory Framework
      • 6.6.4.5. Reimbursement Scenario
      • 6.6.4.6. UAE Central lab market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Regulatory Framework
      • 6.6.5.5. Reimbursement Scenario
      • 6.6.5.6. Kuwait Central lab market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant's overview
  • 7.2. Financial performance
  • 7.3. Participant categorization
    • 7.3.1. Market Leaders
    • 7.3.2. Central Lab Market Share Analysis, 2023
    • 7.3.3. Company Profiles
      • 7.3.3.1. ACM Global Laboratories
      • 7.3.3.1.1. Company Overview
      • 7.3.3.1.2. Financial Performance
      • 7.3.3.1.3. Product Benchmarking
      • 7.3.3.1.4. Strategic Initiatives
      • 7.3.3.2. LabConnect
      • 7.3.3.2.1. Company Overview
      • 7.3.3.2.2. Financial Performance
      • 7.3.3.2.3. Product Benchmarking
      • 7.3.3.2.4. Strategic Initiatives
      • 7.3.3.3. Cerba Research
      • 7.3.3.3.1. Company Overview
      • 7.3.3.3.2. Financial Performance
      • 7.3.3.3.3. Product Benchmarking
      • 7.3.3.3.4. Strategic Initiatives
      • 7.3.3.4. Eurofins Scientific
      • 7.3.3.4.1. Company Overview
      • 7.3.3.4.2. Financial Performance
      • 7.3.3.4.3. Product Benchmarking
      • 7.3.3.4.4. Strategic Initiatives
      • 7.3.3.5. Versiti (Cenetron)
      • 7.3.3.5.1. Company Overview
      • 7.3.3.5.2. Financial Performance
      • 7.3.3.5.3. Product Benchmarking
      • 7.3.3.5.4. Strategic Initiatives
      • 7.3.3.6. Medicover Integrated Clinical Services (MICS) (Synevo Central Labs)
      • 7.3.3.6.1. Company Overview
      • 7.3.3.6.2. Financial Performance
      • 7.3.3.6.3. Product Benchmarking
      • 7.3.3.6.4. Strategic Initiatives
      • 7.3.3.7. A.P. Møller Holding A/S (Unilabs)
      • 7.3.3.7.1. Company Overview
      • 7.3.3.7.2. Financial Performance
      • 7.3.3.7.3. Product Benchmarking
      • 7.3.3.7.4. Strategic Initiatives
      • 7.3.3.8. Ampersand Capital Partners (Pacific Biomarkers)
      • 7.3.3.8.1. Company Overview
      • 7.3.3.8.2. Financial Performance
      • 7.3.3.8.3. Product Benchmarking
      • 7.3.3.8.4. Strategic Initiatives
      • 7.3.3.9. Lambda Therapeutic Research Ltd
      • 7.3.3.9.1. Company Overview
      • 7.3.3.9.2. Financial Performance
      • 7.3.3.9.3. Product Benchmarking
      • 7.3.3.9.4. Strategic Initiatives
      • 7.3.3.10. CIRION BioPharma Research Inc.
      • 7.3.3.10.1. Company Overview
      • 7.3.3.10.2. Financial Performance
      • 7.3.3.10.3. Product Benchmarking
      • 7.3.3.10.4. Strategic Initiatives
    • 7.3.4. Strategy Mapping
      • 7.3.4.1. Expansion
      • 7.3.4.2. Acquisition
      • 7.3.4.3. Collaborations
      • 7.3.4.4. Disease Type/Drug Class Launch
      • 7.3.4.5. Partnerships
      • 7.3.4.6. Others

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 3 Global Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 4 Global Central Lab Market, by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 7 North America Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 9 U.S. Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 Canada Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 11 Canada Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Europe Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 13 Europe Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 14 Europe Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Germany Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 16 Germany Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 UK Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 18 UK Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 France Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 20 France Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Italy Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Italy Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Spain Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 24 Spain Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 26 Denmark Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Sweden Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Norway Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 30 Norway Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 China Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 35 China Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Japan Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 37 Japan Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 India Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 39 India Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 South Korea Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 41 South Korea Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Australia Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 Australia Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Thailand Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 45 Thailand Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Latin America Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 48 Latin America Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Brazil Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 50 Brazil Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Mexico Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 52 Mexico Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 54 Argentina Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 South Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 59 South Africa Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 UAE Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 63 UAE Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Central Lab Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Central Lab Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Central Lab Market: Service Movement Analysis
  • Fig. 15 Global Central Lab Market, by Genetic Services, 2018 - 2030 (USD Million)
  • Fig. 16 Global Central Lab Market, by Biomarker Services, 2018 - 2030 (USD Million)
  • Fig. 17 Global Central Lab Market, by Anatomic Pathology/Histology, 2018 - 2030 (USD Million)
  • Fig. 18 Global Central Lab Market, by Specimen Management & Storage, 2018 - 2030 (USD Million)
  • Fig. 19 Global Central Lab Market, by Special Chemistry Services, 2018 - 2030 (USD Million)
  • Fig. 20 Global Central Lab Market, by Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Central Lab Market: End-Use Movement Analysis
  • Fig. 22 Global Central Lab Market, by Pharmaceutical Companies 2018 - 2030 (USD Million)
  • Fig. 23 Global Central Lab Market, by Biotechnology Companies 2018 - 2030 (USD Million)
  • Fig. 24 Global Central Lab Market, by Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 25 Regional Marketplace: Key Takeaways
  • Fig. 26 Regional Outlook, 2023 & 2030
  • Fig. 27 Global Central Lab Market: Region Movement Analysis
  • Fig. 28 North America Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 33 UK Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 34 France Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 35 Italy Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 36 Spain Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 39 Norway Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 41 Japan Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 42 China Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 43 India Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 44 Australia Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 46 Thailand Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Central Lab Market, 2018 - 2030 (USD Million)